| Autor: |
Salle L; Inserm, U1094, IRD, U270, EpiMaCT-Épidémiologie des Maladies Chroniques en Zone Tropicale, 2 Rue du Dr Marcland, 87025 Limoges, France.; CHU de Limoges, Service d'Endocrinologie-Diabétologie-Maladies Métaboliques, 2 Avenue Martin Luther King, 87042 Limoges, France., Foulatier O; Ligue Contre l'Obésité, 24 Rue Tronchet, 75008 Paris, France.; Clinique Croix Saint Michel, 40 Avenue Charles de Gaulle, 82000 Montauban, France., Coupaye M; AFERO (Association Française d'Etude et de Recherche sur l'Obésité), 1 Avenue du Pr Jean Poulhès, BP 84225, 31400 Toulouse, France.; Centre Intégré Nord Francilien de Prise en Charge de l'Obésité (CINFO), Assistance Publique-Hôpitaux de Paris, Service des Explorations Fonctionnelles, Hôpital Louis-Mourier, 92700 Colombes, France., Frering V; Clinique de la Sauvegarde, Espace Médico-Chirurgical, Immeuble Trait d'Union, Entrée A29, Av des Sources, 69009 Lyon, France., Constantin A; Ligue Contre l'Obésité, 24 Rue Tronchet, 75008 Paris, France., Joly AS; Collectif National des Associations d'Obèses, 62 Rue Jean Jaurès, 92800 Puteaux, France., Braithwaite B; Sanoïa e-Health Services, 188 Av 2nd Division Blindée, 13420 Gémenos, France., Gharbi F; Novo Nordisk, Carré Michelet, 12 Cours Michelet, 92800 Puteaux, France., Jubin L; Novo Nordisk, Carré Michelet, 12 Cours Michelet, 92800 Puteaux, France. |
| Abstrakt: |
Background/Objectives: ACTION-FRANCE (Awareness, Care, and Treatment In Obesity maNagement in France) aims to identify the perceptions, attitudes, behaviors, and potential barriers to effective obesity management in France and guide collaborative actions. Methods: ACTION-FRANCE is a cross-sectional survey of people with obesity (PwO) and healthcare professionals (HCPs) in France. The PwO and HCP survey questionnaire periods ran from 27 September 2022 to 1 February 2023 and from 19 December 2022 to 31 March 2023, respectively. Results: The study, encompassing 1226 PwO and 166 HCPs, reveals a shared recognition of obesity as a chronic condition. However, despite being requested by most PwO, weight-related discussions are surprisingly infrequent, leading to delayed diagnosis and care. PwO and HCPs held different views as to why: HCPs often attributed it to PwO's lack of motivation or disinterest, whereas PwO avoided them because they felt weight management was their own responsibility and were uncomfortable discussing it. When weight was discussed, primarily with general practitioners (GPs), discussions mostly focused on physical activity and diet. However, results identified the strong psychosocial impact of obesity: 42% of respondents reported anxiety/depressive symptoms, and many more hesitated to engage in certain social activities because of their weight. Psychotherapy was only discussed by 55% of HCPs. Pharmaceutical options were also rarely discussed (19.5% of HCPs), though 56.1% of PwO reported they would want to. Conclusions: HCPs' and PwO's perceptions differed significantly and need to converge through enhanced communication. A holistic approach, integrating comprehensive training for GPs and recognizing psychological comorbidities, would help to bridge perceptual gaps effectively and foster more empathetic and effective patient care. |
